Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Sequential Compression System Companies and Organizational Growth Plans 2026

Date : 13 March 2026

Top Companies in the Sequential Compression System Market & Their Offerings

Sequential Compression System Market Companies Cardinal Health, Arjo, Tactile Medical, Bio Compression Systems, Enovis, Mego Afek

Download a free Sequential Compression System Market preview with important data, segments, and competitor insights: Download Now

Company Offerings

Companies Headquarters Offerings
Cardinal Health Ohio, USA Develops sequential compression devices and disposable compression sleeves designed to support blood circulation and help reduce the risk of blood clots in hospitalized or post-surgical patients.
Arjo Sweden Provides intermittent pneumatic compression systems and patient mobility solutions that assist healthcare providers in preventing circulatory complications in immobile patients.
Tactile Medical Minnesota, USA Offers advanced pneumatic compression therapy systems mainly used for managing lymphedema and other circulation-related conditions in clinical and home-care settings
Bio Compression Systems Pennsylvania, USA Manufactures pneumatic compression pumps and garments designed to improve lymphatic and venous circulation and support edema management.
Enovis Delaware, USA Through its rehabilitation and recovery product portfolio, the company provides compression therapy technologies used in post-surgical care and circulatory health management.
Mego Afek Israel Produces compression therapy systems such as pneumatic devices designed to treat lymphedema and support improved blood and lymphatic flow.
Zimmer Biomet Indiana, USA Supplies surgical care and recovery technologies, including compression solutions used to help prevent circulatory complications after orthopedic procedures.
AIROS Medical Pennsylvania, USA Develops pneumatic compression devices that assist in improving blood and lymph circulation and reducing swelling associated with vascular and lymphatic disorders

Supply Chain Analysis

R&D

  • Research and development in sequential compression systems (SCS) is increasingly focused on developing portable, smart, and wearable devices instead of traditional, stationary hospital equipment. These innovations aim to improve patient comfort, increase treatment adherence, and enhance clinical outcomes in the prevention of deep vein thrombosis (DVT).
  • Key players: Cardinal Health, Medtronic, DJO Global, and Arjo.

Clinical Trials

  • Clinical trials studies on sequential compression devices (SCDs) mainly evaluate their effectiveness in preventing venous thromboembolism and reducing edema. Recent trials are also exploring wearable and battery-powered compression devices designed to enhance patient comfort and improve treatment adherence.
  • Key players: Bio Compression Systems, Devon Medical Products, NormaTec, and AIROS Medical.

Patient Support and Services

Sequential compression devices (SCDs), also known as intermittent pneumatic compression systems, are used to improve blood circulation in the legs and help prevent conditions such as deep vein thrombosis and pulmonary embolism in patients with limited mobility. Support services focus on proper device usage, patient monitoring, and ensuring effective therapy, especially during post-surgical recovery. Key players: Zimmer Biomet, Breg Inc., Talley Group Ltd, and Mego Afek.

Market Growth

The global sequential compression system market size was estimated at USD 1.3 billion in 2025 and is predicted to increase from USD 1.41 billion in 2026 to approximately USD 2.9 billion by 2035, expanding at a CAGR of 8.37% from 2026 to 2035.

Sequential Compression System Market Size is USD 1.41 Billion in 2026.

Recent Developments in the Sequential Compression System Market

  • In October 2025, ManaMed received U.S. Food and Drug Administration 510(k) clearance for its PlasmaFlow X sequential compression system. The device is a compact, tubeless system designed to support patient recovery. As a Class II medical device, it includes smart features, improved portability, and longer battery performance, allowing convenient and efficient compression therapy.
  • In November 2024, Cardinal Health introduced the Kendall SCD SmartFlow Compression System in the U.S. as a new addition to its compression therapy portfolio. The system uses advanced intermittent pneumatic compression technology to improve blood circulation in high-risk patients. It is designed to help prevent venous thromboembolism while also enhancing patient comfort and supporting healthcare providers with a more efficient treatment process.

One place. One platform. Complete visibility into the Sequential Compression System Market - Access the Dashboard

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales